You are here: Industry Insights > AD

News List

Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China ACN Newswire
May 07, 2025
Everest Medicines announced that the supplemental New Drug Application (sNDA) for NEFECON has received full approval from the China National Medical Products Administration (NMPA).
Radioconjugates: Targeting for Precision Suzanne Elvidge
May 06, 2025
The development of radioconjugates – targeted molecules designed to carry radionuclides directly to cancerous cells, lowering systemic exposure and increasing the precision of treatment.
mRNA Technology for Vaccines and Broader Applications Saher Haider
May 06, 2025
Messenger RNA (mRNA) Technology has swiftly made its way to the field of vaccinology, offering a novel approach to immunization that differs fundamentally from traditional mechanisms of vaccination.
Taking Over the "King of Medicine"? Chinese Enterprises Lead the Development of PD-(L)1/VEGF Bispecific Antibody Antitumor Drug Kevin
April 28, 2025
PD-(L)1 and VEGF (vascular endothelial growth factor) bispecific antibody therapies are considered a key direction for future tumor treatments, attracting increasing global interest due to their unique mechanism of action and promising clinical data.
Another BlockBuster in HKEX18A Biotech Companies: IPO of DualityBio in Hong Kong, Introducing New Capital Engine in the ADC Field? Kevin
April 15, 2025
On April 15, DualityBio, a rising star in the ADC field, was officially listed on the HKEX, marking one of the most high-profile IPOs in recent years in Chapter 18A Biotech Companies.
NAD+ Application in Pharmaceutical Industry and Regulatory Status in Multiple Countries and Markets Nurah Ekhlaque
April 25, 2025
This article highlights key applications, clinical trial developments, and regulatory classifications of NAD? and its derivatives across major global markets.
Top 10 Sales Volume of New Drugs of Traditional Chinese Medicine: Behind the Numbers - Only 2 Out of 29 Surpassed RMB 100 Million in Sales Xiao Yan
March 14, 2025
From 2016 - 2024, TCM new drugs made progress but lagged in sales. This article analyzes reasons and explores future directions.
A Decade of Transformation in China's Innovative Drug Industry: The Journey from Follower to Leader Kevin
March 14, 2025
Over the past decade, China's innovative drug market has experienced remarkable transformation and growth. With the combined drive of policies, technology, and capital, China's innovative drug industry has entered a golden period of growth. This paper pro
Data of InnoCare's ICP-488 for the Treatment of Psoriasis Presented at Late Breaking Oral Presentation of 2025 AAD PharmaSources
March 11, 2025
InnoCare Pharma; TYK2 inhibitor ICP - 488; psoriasis; 2025 AAD Annual Meeting; clinical data
The Global Pharmaceutical Machinery Market and the Advantage of the Chinese Machinery Market PharmaSources
February 18, 2025
The global pharmaceutical machinery market is growing. The Chinese machinery market has advantages like low costs, large - scale production, and technology adoption.